文献速递冠心病外科

PCI与CABG试验中自发性心肌梗死差异与死亡率关系的系统综述与荟萃分析

Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis.
PubMed 文献 · J Thorac Cardiovasc Surg · 2021-04-29

总体PCI与更高的全因死亡率相关(发生率比1.13,95%CI 1.01-1.28)。亚组分析显示,仅在CABG组SMI显著降低的试验中,CABG的生存获益才显著(交互作用P=0.02)。

要点

  • PCI与CABG试验中,CABG组SMI显著降低仅见于7项试验(35%)。
  • 总体PCI与全因死亡率增加相关(发生率比1.13,95%CI 1.01-1.28)。
  • CABG生存获益仅见于SMI显著降低的试验(交互作用P=0.02)。

核心结论

  • 在已发表的PCI与CABG试验中,外科组全因死亡率的降低与CABG对SMI的保护作用相关。

研究设计与样本

  • 采用通用逆方差法合并结局,以发生率比的自然对数表示。
  • 进行亚组分析和交互作用检验,比较报告与未报告CABG组SMI显著降低的试验间主要结局差异。

主要发现

  • 总体PCI与显著更高的全因死亡率相关(发生率比1.13;95%CI 1.01-1.28)。
  • 亚组分析中,仅报告CABG组SMI显著降低的试验显示CABG生存获益显著(交互作用P=0.02)。

关键数值与推荐

  • 主要结局为全因死亡率,次要结局为SMI。
  • 全因死亡率发生率比1.13(95%CI 1.01-1.28),PCI组更高。
  • 交互作用P=0.02。

临床怎么用

  • 在解读PCI与CABG试验的生存差异时,应考虑CABG对SMI的保护作用。
  • SMI降低可能是CABG生存获益的重要机制,支持在血运重建决策中关注SMI预防。

局限性

  • 仅纳入报告SMI结局的RCT,可能存在选择偏倚。
  • SMI定义和报告方式在各试验间可能不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: It has been hypothesized that the survival benefit of coronary artery bypass (CABG) compared with percutaneous interventions (PCI) may be associated with the reduction in spontaneous myocardial infarction (SMI) achieved by surgery. This, however, has not been formally investigated. The present meta-analysis aims to evaluate the association between the difference in SMI and in survival in PCI versus CABG randomized controlled trials (RCTs). METHODS: A systematic search was performed to identify all RCTs comparing PCI with CABG for the treatment of coronary artery disease and reporting SMI outcomes. Generic inverse variance method was used to pool outcomes as natural logarithms of the incident rate ratios across studies. Subgroup analysis and interaction test were used to compare the difference of the primary outcome among trials that did and did not report a significant reduction in SMI- in the patients treated by CABG. Primary outcome was all-cause mortality; secondary outcome was SMI. RESULTS: Twenty RCTs were included in the meta-analysis. A statistically significant difference in SMI in favor of CABG was found in 7 of the included trials (35%). Overall, PCI was associated with significantly greater all-cause mortality (incident rate ratio, 1.13; 95% confidence interval, 1.01-1.28). At subgroup analysis, a significant difference in survival in favor of CABG was seen only in trials that reported a significant reduction in SMI in the surgical arm (P for interaction 0.02). CONCLUSIONS: In the published PCI versus CABG trials, the reduction in all-cause mortality in the surgical arm is associated with the protective effect of CABG against SMI.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Gaudino M, Di Franco A, Spadaccio C, et al. Difference in spontaneous myocardial infarction and mortality in percutaneous versus surgical revascularization trials: A systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2021. PMID: 34045061. doi:10.1016/j.jtcvs.2021.04.062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。